Lupin acquires Boehringer Ingelheim's brands Ondero and Ondero Met to expand diabetes portfolio in India
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Need to harmonize traditional and modern medicine to combat alarming health problems
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Doxycycline Hyclate Delayed-Release Tablets USP (RLD Doryx ) had estimated annual sales of USD 9 million in the U.S. (IQVIA MAT June 2023).
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated